CVS Health Co. (NYSE:CVS) Shares Sold by Patrick M Sweeney & Associates Inc.

Patrick M Sweeney & Associates Inc. lessened its holdings in shares of CVS Health Co. (NYSE:CVS) by 0.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,338 shares of the pharmacy operator’s stock after selling 272 shares during the period. CVS Health makes up approximately 1.8% of Patrick M Sweeney & Associates Inc.’s portfolio, making the stock its 12th biggest holding. Patrick M Sweeney & Associates Inc.’s holdings in CVS Health were worth $2,394,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Farther Finance Advisors LLC raised its stake in shares of CVS Health by 27.2% during the 1st quarter. Farther Finance Advisors LLC now owns 16,278 shares of the pharmacy operator’s stock worth $1,107,000 after buying an additional 3,481 shares during the last quarter. Daymark Wealth Partners LLC raised its stake in CVS Health by 24.2% during the first quarter. Daymark Wealth Partners LLC now owns 32,967 shares of the pharmacy operator’s stock worth $2,233,000 after purchasing an additional 6,430 shares during the period. Portside Wealth Group LLC boosted its holdings in CVS Health by 14.7% in the first quarter. Portside Wealth Group LLC now owns 30,835 shares of the pharmacy operator’s stock valued at $2,089,000 after acquiring an additional 3,956 shares during the last quarter. Toth Financial Advisory Corp grew its holdings in shares of CVS Health by 15.0% during the 1st quarter. Toth Financial Advisory Corp now owns 37,149 shares of the pharmacy operator’s stock worth $2,517,000 after purchasing an additional 4,846 shares during the period. Finally, Baldwin Wealth Partners LLC MA purchased a new stake in CVS Health during the first quarter worth approximately $247,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CVS. Piper Sandler boosted their price objective on CVS Health from $72.00 to $74.00 and gave the stock an “overweight” rating in a research note on Friday, March 21st. UBS Group raised their target price on CVS Health from $67.00 to $71.00 and gave the company a “neutral” rating in a report on Friday, May 2nd. Robert W. Baird increased their price objective on shares of CVS Health from $51.00 to $71.00 and gave the company a “neutral” rating in a research report on Tuesday, April 15th. Wolfe Research boosted their target price on shares of CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 11th. Finally, Wall Street Zen upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Two equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $74.75.

CVS Health Stock Performance

Shares of CVS opened at $63.61 on Monday. The firm has a fifty day moving average of $65.21 and a 200-day moving average of $59.94. The company has a market cap of $80.47 billion, a price-to-earnings ratio of 17.38, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $72.51.

CVS Health (NYSE:CVS) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The firm had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same period in the previous year, the business posted $1.31 EPS. CVS Health’s revenue was up 7.0% on a year-over-year basis. As a group, equities analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.18%. CVS Health’s dividend payout ratio is presently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.